Reuters logo
BRIEF-iNtRON Biotechnology receives patent
November 28, 2017 / 2:25 AM / 19 days ago

BRIEF-iNtRON Biotechnology receives patent

Nov 28 (Reuters) - iNtRON Biotechnology Inc :

* Says it received patent on Nov. 27, for pharmaceutical composition containing fk506 derivative for treating fungal infection caused by genus cryptococcus and genus candida and use thereof

Source text in Korean: goo.gl/QmHseK

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below